After Profitable Year, Genomic Health to Invest in New Products, Overseas Market, Next-Gen Sequencing | GenomeWeb

By Turna Ray

A decade after its launch, Genomic Health has achieved what many molecular diagnostics companies only dream of by reporting its first profitable year.

Genomic Health last week reported a net income of $4.3 million for the 12 months ended Dec. 31, 2010, compared with a net loss of $9.4 million in 2009. Full-year revenues increased 19 percent to $178 million from $150 million in 2009, while product revenue also rose 19 percent to $175 million from $146.6 million in the year-ago period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.